RGD peptide-modified multifunctional dendrimer platform for drug encapsulation and targeted inhibition of cancer cells

Colloids and Surfaces B: Biointerfaces

Volumn 125, Issue , 2015, Pages 82-89

  He, Xuedan ^a   Alves, Carla S ^a   Oliveira, Nilsa ^a   Rodrigues, João ^a   Zhu, Jingyi ^b   Bányai, István ^c   Tomás, Helena ^a   Shi, Xiangyang ^a,b  

^a UNIVERSITY OF MADEIRA   (Portugal)

^b DONGHUA UNIVERSITY   (China)

^c UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Dendrimers; Doxorubicin; Host guest interaction; RGD peptide; Targeted cancer therapy

Indexed keywords

ACETYLATION; AMINO ACIDS; CELLS; CYTOLOGY; DENDRIMERS; DISEASES; DRUG DELIVERY; DRUG INTERACTIONS; ENCAPSULATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ONCOLOGY; PEPTIDES;

ARGININE-GLYCINE-ASPARTIC ACIDS; DOXORUBICIN; FLUORESCEIN ISOTHIOCYANATE; HOST GUEST INTERACTIONS; ONE-AND TWO-DIMENSIONAL NMR; POLYAMIDOAMINE DENDRIMERS; RGD PEPTIDE; TARGETED CANCER THERAPY;

FUNCTIONAL POLYMERS;

ARGINYLGLYCYLASPARTIC ACID; DENDRIMER; DOXORUBICIN; FLUORESCEIN ISOTHIOCYANATE; MACROGOL; POLYAMIDOAMINE; VITRONECTIN RECEPTOR; ANTINEOPLASTIC ANTIBIOTIC; ARGINYL-GLYCYL-ASPARTIC ACID; DRUG CARRIER; FLUORESCENT DYE; MACROGOL DERIVATIVE; OLIGOPEPTIDE; POLYAMINE; THIOUREA;

ACETYLATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER INHIBITION; COMPLEX FORMATION; DRUG DOSAGE FORM COMPARISON; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; DRUG TARGETING; ENCAPSULATION; HUMAN; HUMAN CELL; MOLECULARLY TARGETED THERAPY; NUCLEAR MAGNETIC RESONANCE; PH; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; DRUG FORMULATION; GENE EXPRESSION; GENETICS; GLIA; METABOLISM; STAINING; SYNTHESIS; TUMOR CELL LINE;

ACETYLATION; ANTIBIOTICS, ANTINEOPLASTIC; CELL LINE, TUMOR; CELL SURVIVAL; DENDRIMERS; DOXORUBICIN; DRUG CARRIERS; DRUG COMPOUNDING; DRUG LIBERATION; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; GENE EXPRESSION; HUMANS; HYDROGEN-ION CONCENTRATION; INTEGRIN ALPHAVBETA3; NEUROGLIA; OLIGOPEPTIDES; POLYAMINES; POLYETHYLENE GLYCOLS; STAINING AND LABELING; THIOUREA;

EID: 84912079021     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2014.11.004     Document Type: Article

References (66)

1. Peer D., Karp J.M., Hong S., Farokhzad O.C., Margalit R., Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2007, 2:751-760.
2. Wang Y., Cao X., Guo R., Shen M., Zhang M., Zhu M., Shi X. Targeted delivery of doxorubicin into cancer cells using a folic acid-dendrimer conjugate. Polym. Chem. 2011, 2:1754-1760.
3. Wang Y., Guo R., Cao X., Shen M., Shi X. Encapsulation of 2-methoxyestradiol within multifunctional poly(amidoamine) dendrimers for targeted cancer therapy. Biomaterials 2011, 32:3322-3329.
4. Panyam J., Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 2003, 55:329-347.
5. Xiao T., Hou W., Cao X., Wen S., Shen M., Shi X. Dendrimer-entrapped gold nanoparticles modified with folic acid for targeted gene delivery applications. Biomater. Sci. 2013, 1:1172-1180.
6. Shan Y., Luo T., Peng C., Sheng R., Cao A., Cao X., Shen M., Guo R., Tomás H., Shi X. Gene delivery using dendrimer-entrapped gold nanoparticles as nonviral vectors. Biomaterials 2012, 33:3025-3035.
7. Brambilla D., Nicolas J., Le Droumaguet B., Andrieux K., Marsaud V., Couraud P.-O., Couvreur P. Design of fluorescently tagged poly(alkyl cyanoacrylate) nanoparticles for human brain endothelial cell imaging. Chem. Commun. 2010, 46:2602-2604.
8. Liu H., Xu Y., Wen S., Chen Q., Zheng L., Shen M., Zhao J., Zhang G., Shi X. Targeted tumor computed tomography imaging using low-generation dendrimer-stabilized gold nanoparticles. Chem. Eur. J. 2013, 19:6409-6416.
9. Peng C., Zheng L., Chen Q., Shen M., Guo R., Wang H., Cao X., Zhang G., Shi X. PEGylated dendrimer-entrapped gold nanoparticles for in vivo blood pool and tumor imaging by computed tomography. Biomaterials 2012, 33:1107-1119.
10. Shi X., Wang S.H., Swanson S.D., Ge S., Cao Z., Van Antwerp M.E., Landmark K.J., Baker J.R. Dendrimer-functionalized shell-crosslinked iron oxide nanoparticles for in-vivo magnetic resonance imaging of tumors. Adv. Mater. 2008, 20:1671-1678.
11. Zheng L., Zhu J., Shen M., Chen X., Baker J.R., Wang S.H., Zhang G., Shi X. Targeted cancer cell inhibition using multifunctional dendrimer-entrapped gold nanoparticles. Med. Chem. Commun. 2013, 4:1001-1005.
12. Zhu J., Zheng L., Wen S., Tang Y., Shen M., Zhang G., Shi X. Targeted cancer theranostics using alpha-tocopheryl succinate-conjugated multifunctional dendrimer-entrapped gold nanoparticles. Biomaterials 2014, 35:7635-7646.
13. Zhou Z., Kong B., Yu C., Shi X., Wang M., Liu W., Sun Y., Zhang Y., Yang H., Yang S. Tungsten oxide nanorods: an efficient nanoplatform for tumor CT imaging and photothermal therapy. Sci. Rep. 2014, 4:3653.
14. Li K., Wang S., Wen S., Tang Y., Li J., Shi X., Zhao Q. Enhanced in vivo antitumor efficacy of doxorubicin encapsulated within laponite nanodisks. ACS Appl. Mater. Interfaces 2014, 6:12328-12334.
15. Zhang M., Guo R., Wang Y., Cao X., Shen M., Shi X. Multifunctional dendrimer/combretastatin A4 inclusion complexes enable in vitro targeted cancer therapy. Int. J. Nanomed. 2011, 6:2337-2349.
16. Zheng Y., Fu F., Zhang M., Shen M., Zhu M., Shi X. Multifunctional dendrimers modified with alpha-tocopheryl succinate for targeted cancer therapy. Med. Chem. Commun. 2014, 5:879-885.
17. Yih T., Al-Fandi M. Engineered nanoparticles as precise drug delivery systems. J. Cell. Biochem. 2006, 97:1184-1190.
18. Vauthier C., Dubernet C., Chauvierre C., Brigger I., Couvreur P. Drug delivery to resistant tumors: the potential of poly(alkyl cyanoacrylate) nanoparticles. J. Control. Rel. 2003, 93:151-160.
19. Pan D., Guo C., Luo K., Yi Q., Gu Z. PEGylated dendritic diaminocyclohexyl-platinum (II) conjugates as pH-responsive drug delivery vehicles with enhanced tumor accumulation and antitumor efficacy. Biomaterials 2014, 35:10080-10092.
20. She W., Li N., Luo K., Guo C., Wang G., Geng Y., Gu Z. Dendronized heparin-doxorubicin conjugate based nanoparticle as pH-responsive drug delivery system for cancer therapy. Biomaterials 2013, 34:2252-2264.
21. She W., Luo K., Zhang C., Wang G., Geng Y., Li L., He B., Gu Z. The potential of self-assembled, pH-responsive nanoparticles of mPEGylated peptide dendron-doxorubicin conjugates for cancer therapy. Biomaterials 2013, 34:1613-1623.
22. Parveen S., Misra R., Sahoo S.K. Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomed.-Nanotechnol. Biol. Med. 2012, 8:147-166.
23. Tomalia D., Reyna L., Svenson S. Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging. Biochem. Soc. Trans. 2007, 35:61-67.
24. Majoros I.J., Thomas T.P., Mehta C.B., Baker J.R. Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy. J. Med. Chem. 2005, 48:5892-5899.
25. Zhu J., Shi X. Dendrimer-based nanodevices for targeted drug delivery applications. J. Mater. Chem. B 2013, 1:4199-4211.
26. Thomas T.P., Majoros I.J., Kotlyar A., Kukowska-Latallo J.F., Bielinska A., Myc A., Baker J.R. Targeting and inhibition of cell growth by an engineered dendritic nanodevice. J. Med. Chem. 2005, 48:3729-3735.
27. Kukowska-Latallo J.F., Candido K.A., Cao Z., Nigavekar S.S., Majoros I.J., Thomas T.P., Balogh L.P., Khan M.K., Baker J.R. Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res. 2005, 65:5317-5324.
28. Morgan M.T., Nakanishi Y., Kroll D.J., Griset A.P., Carnahan M.A., Wathier M., Oberlies N.H., Manikumar G., Wani M.C., Grinstaff M.W. Dendrimer-encapsulated camptothecins: increased solubility, cellular uptake, and cellular retention affords enhanced anticancer activity in vitro. Cancer Res. 2006, 66:11913-11921.
29. Dhanikula R.S., Argaw A., Bouchard J.-F., Hildgen P. Methotrexate loaded polyether-copolyester dendrimers for the treatment of gliomas: enhanced efficacy and intratumoral transport capability. Mol. Pharmaceutics 2008, 5:105-116.
30. Shi X., Wang S., Meshinchi S., Van Antwerp M.E., Bi X., Lee I., Baker J.R. Dendrimer-entrapped gold nanoparticles as a platform for cancer-cell targeting and imaging. Small 2007, 3:1245-1252.
31. Majoros I.J., Myc A., Thomas T., Mehta C.B., Baker J.R. PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality. Biomacromolecules 2006, 7:572-579.
32. Shi X., Wang S.H., Shen M., Antwerp M.E., Chen X., Li C., Petersen E.J., Huang Q., Weber W.J., Baker J.R. Multifunctional dendrimer-modified multiwalled carbon nanotubes: synthesis, characterization, and in vitro cancer cell targeting and imaging. Biomacromolecules 2009, 10:1744-1750.
33. Shi X., Thomas T.P., Myc L.A., Kotlyar A., Baker J.R. Synthesis, characterization, and intracellular uptake of carboxyl-terminated poly(amidoamine) dendrimer-stabilized iron oxide nanoparticles. Phys. Chem. Chem. Phys. 2007, 9:5712-5720.
34. Chen H.-T., Neerman M.F., Parrish A.R., Simanek E.E. Cytotoxicity, hemolysis, and acute in vivo toxicity of dendrimers based on melamine, candidate vehicles for drug delivery. J. Am. Chem. Soc. 2004, 126:10044-10048.
35. Kim Y., Klutz A.M., Jacobson K.A. Systematic investigation of polyamidoamine dendrimers surface-modified with poly(ethylene glycol) for drug delivery applications: synthesis, characterization, and evaluation of cytotoxicity. Bioconjugate Chem. 2008, 19:1660-1672.
36. Liao H., Liu H., Li Y., Zhang M., Tomás H., Shen M., Shi X. Antitumor efficacy of doxorubicin encapsulated within PEGylated poly(amidoamine) dendrimers. J. Appl. Polym. Sci. 2014, 131:40358-40368.
37. Liu H., Wang H., Xu Y., Shen M., Zhao J., Zhang G., Shi X. Synthesis of PEGylated low generation dendrimer-entrapped gold nanoparticles for CT imaging applications. Nanoscale 2014, 6:4521-4526.
38. Gordon A.N., Fleagle J.T., Guthrie D., Parkin D.E., Gore M.E., Lacave A.J. Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan. J. Clin. Oncol. 2001, 19:3312-3322.
39. Lamm D.L., Blumenstein B.A., Crawford E.D., Montie J.E., Scardino P., Grossman H.B., Stanisic T.H., Smith J.A., Sullivan J., Sarosdy M.F. A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guerin for transitional-cell carcinoma of the bladder. N. Engl. J. Med. 1991, 325:1205-1209.
40. Santoro A., Tursz T., Mouridsen H., Verweij J., Steward W., Somers R., Buesa J., Casali P., Spooner D., Rankin E. Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J. Clin. Oncol. 1995, 13:1537-1545.
41. Zhu S., Hong M., Tang G., Qian L., Lin J., Jiang Y., Pei Y. Partly PEGylated polyamidoamine dendrimer for tumor-selective targeting of doxorubicin: the effects of PEGylation degree and drug conjugation style. Biomaterials 2010, 31:1360-1371.
42. Zhang M., Guo R., Kéri M., Bányai I., Zheng Y., Cao M., Cao X., Shi X. Impact of dendrimer surface functional groups on the release of doxorubicin from dendrimer carriers. J. Phys. Chem. B 2014, 118:1696-1706.
43. Choi S.K., Thomas T., Li M.-H., Kotlyar A., Desai A., Baker J.R. Light-controlled release of caged doxorubicin from folate receptor-targeting PAMAM dendrimer nanoconjugate. Chem. Commun. 2010, 46:2632-2634.
44. Li N., Li N., Yi Q., Luo K., Guo C., Pan D., Gu Z. Amphiphilic peptide dendritic copolymer-doxorubicin nanoscale conjugate self-assembled to enzyme-responsive anti-cancer agent. Biomaterials 2014, 35:9529-9545.
45. Zhang C., Pan D., Luo K., Li N., Guo C., Zheng X., Gu Z. Dendrimer-doxorubicin conjugate as enzyme-sensitive and polymeric nanoscale drug delivery vehicle for ovarian cancer therapy. Polym. Chem. 2014, 5:5227-5235.
46. Zhang C., Pan D., Luo K., She W., Guo C., Yang Y., Gu Z. Peptide dendrimer-doxorubicin conjugate-based nanoparticle as an enzyme-responsive drug delivery system for cancer therapy. Adv. Healthcare Mater. 2014, 3:1299-1308.
47. Bhadra D., Bhadra S., Jain S., Jain N. A PEGylated dendritic nanoparticulate carrier of fluorouracil. Int. J. Pharm. 2003, 257:111-124.
48. Shi X., Lee I., Chen X., Shen M., Xiao S., Zhu M., Baker J.R., Wang S.H. Influence of dendrimer surface charge on the bioactivity of 2-methoxyestradiol complexed with dendrimers. Soft Matter 2010, 6:2539-2545.
49. D'Emanuele A., Attwood D. Dendrimer-drug interactions. Adv. Drug Deliv. Rev. 2005, 57:2147-2162.
50. Cho H.-J., Yoon I.-S., Yoon H.Y., Koo H., Jin Y.-J., Ko S.-H., Shim J.-S., Kim K., Kwon I.C., Kim D.-D. Polyethylene glycol-conjugated hyaluronic acid-ceramide self-assembled nanoparticles for targeted delivery of doxorubicin. Biomaterials 2012, 33:1190-1200.
51. Barth R.F., Adams D.M., Soloway A.H., Alam F., Darby M.V. Boronated starburst dendrimer-monoclonal antibody immunoconjugates: evaluation as a potential delivery system for neutron capture therapy. Bioconjugate Chem. 1994, 5:58-66.
52. Dijkgraaf I., Rijnders A.Y., Soede A., Dechesne A.C., van Esse G.W., Brouwer A.J., Corstens F.H., Boerman O.C., Rijkers D.T., Liskamp R.M. Synthesis of DOTA-conjugated multivalent cyclic-RGD peptide dendrimers via 1, 3-dipolar cycloaddition and their biological evaluation: implications for tumor targeting and tumor imaging purposes. Org. Biomol. Chem. 2007, 5:935-944.
53. Han L., Huang R., Li J., Liu S., Huang S., Jiang C. Plasmid pORF-hTRAIL and doxorubicin co-delivery targeting to tumor using peptide-conjugated polyamidoamine dendrimer. Biomaterials 2011, 32:1242-1252.
54. Hill E., Shukla R., Park S.S., Baker J.R. Synthetic PAMAM-RGD conjugates target and bind To odontoblast-like MDPC 23 cells and the predentin in tooth organ cultures. Bioconjugate Chem. 2007, 18:1756-1762.
55. Shukla R., Hill E., Shi X., Kim J., Muniz M.C., Sun K., Baker J.R. Tumor microvasculature targeting with dendrimer-entrapped gold nanoparticles. Soft Matter 2008, 4:2160-2163.
56. Zhu S., Qian L., Hong M., Zhang L., Pei Y., Jiang Y. RGD-modified PEG-PAMAM-DOX conjugate: in vitro and in vivo targeting to both tumor neovascular endothelial cells and tumor cells. Adv. Mater. 2011, 23:H84-H89.
57. Pandita D., Santos J.L., Rodrigues J., Pêgo A.P., Granja P.L., Tomás H. Gene delivery into mesenchymal stem cells: a biomimetic approach using RGD nanoclusters based on poly(amidoamine) dendrimers. Biomacromolecules 2011, 12:472-481.
58. Santos J.L., Oliveira H., Pandita D., Rodrigues J., Pêgo A.P., Granja P.L., Tomás H. Functionalization of poly(amidoamine) dendrimers with hydrophobic chains for improved gene delivery in mesenchymal stem cells. J. Control. Rel. 2010, 144:55-64.
59. Nasongkla N., Shuai X., Ai H., Weinberg B.D., Pink J., Boothman D.A., Gao J. cRGD-functionalized polymer micelles for targeted doxorubicin delivery. Angew. Chem. Int. Ed. 2004, 116:6483-6487.
60. Chen Q., Li K., Wen S., Liu H., Peng C., Cai H., Shen M., Zhang G., Shi X. Targeted CT/MR dual mode imaging of tumors using multifunctional dendrimer-entrapped gold nanoparticles. Biomaterials 2013, 34:5200-5209.
61. Liu H., Wang H., Xu Y., Guo R., Wen S., Huang Y., Liu W., Shen M., Zhao J., Zhang G., Shi X. Lactobionic acid-modified dendrimer-entrapped gold nanoparticles for targeted computed tomography imaging of human hepatocellular carcinoma. ACS Appl. Mater. Interfaces 2014, 6:6944-6953.
62. Shukla R., Thomas T.P., Peters J., Kotlyar A., Myc A., James J., Baker R. Tumor angiogenic vasculature targeting with PAMAM dendrimer-RGD conjugates. Chem. Commun. 2005, 5739-5741.
63. Cakara D., Kleimann J., Borkovec M. Microscopic protonation equilibria of poly(amidoamine) dendrimers from macroscopic titrations. Macromolecules 2003, 36:4201-4207.
64. Hu J., Cheng Y., Wu Q., Zhao L., Xu T. Host-guest chemistry of dendrimer-drug complexes. 2. Effects of molecular properties of guests and surface functionalities of dendrimers. J. Phys. Chem. B 2009, 113:10650-10659.
65. Chen W., Tomalia D.A., Thomas J.L. Unusual pH-dependent polarity changes in PAMAM dendrimers: evidence for pH-responsive conformational changes. Macromolecules 2000, 33:9169-9172.
66. Cheng S.-H., Lee C.-H., Chen M.-C., Souris J.S., Tseng F.-G., Yang C.-S., Mou C.-Y., Chen C.-T., Lo L.-W. Tri-functionalization of mesoporous silica nanoparticles for comprehensive cancer theranostics-the trio of imaging, targeting and therapy. J. Mater. Chem. 2010, 20:6149-6157.